Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by AscellaHealth
AscellaHealth Expands Executive Team: Industry Veterans Lead Development and Implementation of End-to-End Payer Solutions and Pharmacy Operations to Control Specialty Spend
April 11, 2024
From
AscellaHealth
Via
Business Wire
AscellaHealth Releases Q1 2024 Specialty & Rare Pipeline Digest™: Captures Data and Progress of Groundbreaking Therapies in 2024
March 28, 2024
From
AscellaHealth
Via
Business Wire
AscellaHealth Ranks No. 46 on Inc. Magazine’s List of the Northeast Region’s Fastest-Growing Private Companies
February 28, 2024
From
AscellaHealth
Via
Business Wire
AscellaHealth Provides Specialty & Rare Pipeline Digest™ Recap: Navigating the Path to 2024 Groundbreaking Therapies
January 09, 2024
From
AscellaHealth
Via
Business Wire
AscellaHealth Announces Strategic Global Joint Venture, Forming 4Merit Solutions
December 19, 2023
From
AscellaHealth
Via
Business Wire
AscellaHealth Named 2023 Best Global Specialty Pharmacy & Healthcare Services Organisation
September 26, 2023
From
AscellaHealth
Via
Business Wire
The Committee to Restore Nymox Shareholder Value Soundly Rebuts Injurious Allegations Made by Nymox Pharmaceutical Corp Current Management
July 16, 2023
From
AscellaHealth
Via
Business Wire
Rebuttal Letters Issued to Shareholders of NYMOX PHARMACEUTICAL CORP ("NYMX-Q")
July 09, 2023
From
AscellaHealth
Via
Business Wire
Announcing the Recipients of the 2023 Philadelphia Titan 100
June 22, 2023
From
AscellaHealth
Via
Business Wire
Announcing the recipients of the 2023 Philadelphia Titan 100
June 20, 2023
From
AscellaHealth
Via
Business Wire
AscellaHealth Recognized Among Philadelphia Business Journal’s 2023 Best Places to Work
June 15, 2023
From
AscellaHealth
Via
Business Wire
Specialty Pharma Expert Adopts Name of Global Parent to Reflect Breadth of Offer That Brings a Rare and Special Perspective to the Market
April 25, 2023
From
AscellaHealth
Via
Business Wire
AscellaHealth Ranks No. 48 on Inc. Magazine’s List of the Northeast Region’s Fastest-Growing Private Companies
March 01, 2023
From
AscellaHealth
Via
Business Wire
AscellaHealth Ranked Number 238 Fastest-Growing Company in North America on the 2022 Deloitte Technology Fast 500™
November 16, 2022
From
AscellaHealth
Via
Business Wire
AscellaHealth Family of Companies is Founding Sponsor of Inaugural Gene Therapy and Specialty Pharmacy Awareness Month, September 2022
August 30, 2022
From
AscellaHealth
Via
Business Wire
AscellaHealth Achieves Favorable Ranking Among Prestigious 2022 Inc. Magazine’s 5000 Honorees: The Most Successful Companies in America For Second Consecutive Year
August 24, 2022
From
AscellaHealth
Via
Business Wire
Dea Belazi Named 2022 Titan 100 Award, Recognizing Philadelphia’s Top 100 CEO’s & C-level Executives
July 12, 2022
From
AscellaHealth
Via
Business Wire
AscellaHealth Family of Companies Expands Subsidiary Terebellum’s Operations into Germany and United Kingdom, Adds New Executive Positions
June 07, 2022
From
AscellaHealth
Via
Business Wire
Ernst & Young Names Dea Belazi, CEO and President, AscellaHealth, Entrepreneur Of The Year® 2022 Greater Philadelphia Award Finalist
May 24, 2022
From
AscellaHealth
Via
Business Wire
AscellaHealth Awarded as One of The Financial Times’ “Americas' Fastest Growing Companies 2022” For Contribution to North and South America’s Economic Growth
May 17, 2022
From
AscellaHealth
Via
Business Wire
The AscellaHealth Family of Companies Expands Executive Team Leadership for Ongoing Support of Strategic Business Initiatives and Accelerated Growth
May 03, 2022
From
AscellaHealth
Via
Business Wire
AscellaHealth Launches Family of Companies, Expands Specialty Pharmacy Services and Capabilities to Serve Patients, Payers, Life Sciences and Providers
April 27, 2022
From
AscellaHealth
Via
Business Wire
AscellaHealth’s Hub Solutions for Life Sciences Ensures Specialty Product Access and Market Entry, Optimizes Outcomes for Rare Disease Patients
April 12, 2022
From
AscellaHealth
Via
Business Wire
With a Two-Year Revenue Growth of 279%, AscellaHealth Ranks No. 54 on Inc. Magazine’s List of the Northeast Region’s Fastest-Growing Private Companies
March 15, 2022
From
AscellaHealth
Via
Business Wire
AscellaHealth Offers Home Infusion Pharmacy Network, Complements Site of Care Optimization and Overall Strategy to Cut Costs While Ensuring Care Quality
February 08, 2022
From
AscellaHealth
Via
Business Wire
AscellaHealth Designates Preferred Status to Leading Pharmacies for Home Infusion Pharmacy Network, Enhances Site of Care Optimization
January 18, 2022
From
AscellaHealth
Via
Business Wire
AscellaHealth Expands Pharmaceutical Services for Life Sciences: Pre-Commercialization and Outsourced Market Access Solutions and Patient Support & HUB Services Ensure Optimal Access and Clinical Outcomes
January 11, 2022
From
AscellaHealth
Via
Business Wire
AscellaHealth Launches Expanded Website: User-Friendly Content on Global Specialty Pharmacy and Healthcare Services for Patients, Payers, Life Sciences and Providers
January 06, 2022
From
AscellaHealth
Via
Business Wire
Philadelphia Business Journal Names AscellaHealth President and CEO Dea Belazi Among Top Honorees for Philadelphia Region’s “Most Admired CEOs”
November 11, 2021
From
AscellaHealth
Via
Business Wire
AscellaHealth Earns Merit-Based Philadelphia100 Award for Second Consecutive Year, Ranks Among Fastest Growing, Private Companies in Philadelphia Region
November 02, 2021
From
AscellaHealth
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.